Rifamycin S CAS 13553-79-2
Rifamycin S tertia generatio productum est medicamentorum genere rifampicin, quod magnum habet efficaciam et latum spectrum antibacterial actionis. Magnam sensum habet ad varias bacteria pharmaca communi pharmacopola resistentia. Lipomycin B oxidationem, reductionem, et hydrolysim ad rifampicin natrii producit.
Item | Specification |
fervens | 700.89°C (aestimatio aspera) |
Densitas | 1.2387 (aspens aestimatio) |
punctum liquescens | 179-181°C (dec.) |
pKa | 3.85 ± 0.70 (Predicta) |
resistivity | 1.6630 (aestima) |
Repono conditionibus | -20°C Freezer |
Rifamycin S adhibetur ut medium pharmaceuticum ad inhibendum activitates polymerasium RNA bacterial. Synthesis bacterial RNA impediens, tandem synthesin servulorum ab bacteria requisita claudens, mortem bacterial ducens et effectus bactericidalos exhibens.
Solet in 25kg/orum referta, et sarcina nativus facere potest.
Rifamycin S CAS 13553-79-2
Rifamycin S CAS 13553-79-2
Epistulam tuam hic scribe et mitte nobis